Curaleaf Holdings (CURLF) Current Taxes (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Current Taxes of $19.0 million for Q4 2025, down 19.06% year-on-year from $23.4 million in Q4 2024, and down 19.06% on a QoQ basis from $23.4 million in Q4 2024.
Curaleaf Holdings (CURLF) Current Taxes (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Current Taxes for 7 consecutive years, with $19.0 million the latest figure, recorded in Q4 2025.
- Quarterly Current Taxes fell 19.06% year-over-year to $19.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.0 million (down 19.06% YoY) and the FY2025 annual result came in at $19.0 million, down 19.06% from the prior year.
- Current Taxes retreated to $19.0 million in Q4 2025 per CURLF's latest filing, from $23.4 million in the prior quarter.
- Over the last five years, Current Taxes for CURLF reached as high as $182.9 billion in Q1 2022 and fell as low as $6.2 million in Q2 2024.
- A 5-year average of $12.3 billion and a median of $130.1 million in 2021 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2022 — Current Taxes surged 165991.68% — and 2024, when it sank 97.03%.
- Year by year, Current Taxes stood at $139.2 million in 2021, then increased by 7.47% to $149.6 million in 2022, then jumped by 32.42% to $198.1 million in 2023, then tumbled by 88.18% to $23.4 million in 2024, then dropped by 19.06% to $19.0 million in 2025.
- According to Business Quant data, Current Taxes over the past three periods registered $19.0 million, $23.4 million, and $10.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.95 Mn |
| Dec 31, 2024 | 23.41 Mn |
| Sep 30, 2024 | 10.74 Mn |
| Jun 30, 2024 | 6.24 Mn |
| Dec 31, 2023 | 198.06 Mn |
| Sep 30, 2023 | 237.33 Mn |
| Jun 30, 2023 | 209.91 Mn |
| Dec 31, 2022 | 149.57 Mn |
| Sep 30, 2022 | 167.27 Mn |
| Jun 30, 2022 | 125.27 Mn |
| Mar 31, 2022 | 182.95 Bn |
| Dec 31, 2021 | 139.17 Mn |
| Sep 30, 2021 | 130.14 Mn |
| Jun 30, 2021 | 63.38 Mn |
| Mar 31, 2021 | 110.15 Mn |
| Dec 31, 2020 | 79.65 Mn |
| Sep 30, 2020 | 35.49 Mn |
| Dec 31, 2019 | 15.11 Mn |